Lv1
100 积分 2025-01-14 加入
Bispecific T cell engager therapy for refractory rheumatoid arthritis
12天前
已完结
Discovery of ABBV-154, an anti-TNF Glucocorticoid Receptor Modulator Immunology Antibody-Drug Conjugate (iADC)
13天前
已完结
Efficacy, Safety, Pharmacokinetics, and Immunogenicity of ABBV‐154 in Adults With Glucocorticoid‐Dependent Polymyalgia Rheumatica: A Phase 2, Randomized, Double‐Blind, Placebo‐Controlled Trial
13天前
已完结
An Overview of Property, Design, and Functionality of Linkers for Fusion Protein Construction
19天前
已完结
Trends in the drug target landscape for autoimmune diseases
29天前
已完结
Safety and Efficacy of CT041 in Patients With Refractory Metastatic Pancreatic Cancer: A Pooled Analysis of Two Early-Phase Trials
1个月前
已完结
Linker and Conjugation Site Synergy in Antibody–Drug Conjugates: Impacts on Biological Activity
2个月前
已完结
A Phase 1 Study of a CDH6-Targeting Antibody-Drug Conjugate in Patients with Advanced Solid Tumors with Evaluation of Inflammatory and Neurological Adverse Events
3个月前
已完结
皖公网安备34019202002308
